Costs aren’t just research and purification, it’s also good manufacturing practice and quality control.
Comment on Insulin
fullsquare@awful.systems 2 days agoalso european, but with some background: the problem is that there is natural (as in, unmodified) generic insulin available, it’s just that it sucks compared to everything else. you see, insulin is a peptide that is supposed to appear, do some signalling, then disappear and unmodified insulin copies this thing exactly. the problem is, most of the time, you don’t want to do that, you’d like insulin to last longer than usual, which means changes to it that make breakdown slower, or adding something that makes it stick to albumin, which has similar effect because it hides insulin somewhere enzymes can’t reach it. this means less frequent dosing and less changes in insulin activity over time. there are also other insulins that start acting faster than natural, and this is also due to a couple of modifications in its structure
for another example, ozempic was not the first drug in its class, it’s also a modified peptide, and it can be injected s.c. once a week, compared to previous iteration (liraglutide) that requires daily injections. if natural peptide is injected i.m. instead, its halflife is half an hour, and in serum it’s only two minutes (it gets released a bit slower than it is metabolized)
ryedaft@sh.itjust.works 2 days ago
fullsquare@awful.systems 1 day ago
i mean i don’t think about it as a separate budget line because if you don’t have that you get police raids and investigation instead of normal business, but yea. insulin is purified using HPLC, so at all times you get some of analytical data about fractions you just made, so some of QC, not all, but already something, already happens at this point
my point is that actual manufacturing costs will be low because biotech scalability logic is that you need to make yeast or something that makes peptide you like and then all you need to do is keep bioreactor alive and happy. lots of what is left is in purification
also it’s an injectable so it’s gonna be kept to some standards that non-injected drugs aren’t
Tollana1234567@lemmy.today 1 day ago
thats why the big 3 companies make different version insulin so they are effective at certain times of the day, or when you eat/
fullsquare@awful.systems 1 day ago
there are multiple short-acting and long-acting insulins because you can’t patent other people’s things, but now it’s all off-patent. just take your stainless steel bioreactor and preparative HPLC, cook up a batch, wait ten years for biosimilar approval and you’re good to go
gandalf_der_12te@discuss.tchncs.de 11 hours ago
very interesting!
Sir_Premiumhengst@lemmy.world 2 days ago
Oh wow, an actual nuanced response and genuine answer!
Also today I learned!
buttnugget@lemmy.world 1 day ago
Responses don’t need to be nuanced to be useful.
princessnorah@lemmy.blahaj.zone 1 day ago
Yeah, alright buttnugget.
buttnugget@lemmy.world 1 day ago
Alright Caroline